Effects of icariside II on improving erectile function in rats with streptozotocin-induced diabetes

Journal of Andrology

Volumn 33, Issue 5, 2012, Pages 832-844

  Zhou, Feng ^a   Xin, Hua ^b   Liu, Tao ^a   Li, Guang Yong ^a   Gao, Zhe Zhu ^a   Liu, Jing ^a   Li, Wei Ren ^a   Cui, Wan Shou ^a   Bai, Guang Yi ^a   Park, Nam Cheol ^b   Xin, Zhong Cheng ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Endothelium; Erectile dysfunction; Extracellular matrix; Nitric oxide synthase

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ICARISIDE II; NITRIC OXIDE SYNTHASE; PLACEBO; SMAD2 PROTEIN; SODIUM CHLORIDE; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN; CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, RAT; FLAVONOID; ICARISID II; MADH2 PROTEIN, RAT; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NOS1 PROTEIN, RAT; NOS3 PROTEIN, RAT; PHOSPHODIESTERASE V INHIBITOR; TGFB1 PROTEIN, RAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; ELECTROSTIMULATION; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PENIS; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; STAINING; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANIMAL; DIABETES MELLITUS; DOSE RESPONSE; EXPERIMENTAL DIABETES MELLITUS; EXTRACELLULAR MATRIX; INNERVATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; VASCULARIZATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC GMP; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ERECTILE DYSFUNCTION; EXTRACELLULAR MATRIX; FLAVONOIDS; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; PENILE ERECTION; PENIS; PHOSPHODIESTERASE 5 INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872831139     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.111.015172     Document Type: Article

References (39)

1. Ahn GJ, Sohn YS, Kang KK, Ahn BO, Kwon JW, Kang SK, Lee BC, Hwang WS. The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats. Int J Impot Res. 2005a; 17:134-141.
2. Ahn GJ, Yu JY, Choi SM, Kang KK, Ahn BO, Kwon JW, Kang SK, Lee BC, Hwang WS. Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes. Int J Androl. 2005b;28:260-266.
3. Albersen M, Lin G, Fandel TM, Zhang H, Qiu X, Lin CS, Lue TF. Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction. Urology. 2011;78(2):476.e1-476.e8.
4. Bahk JY, Jung JH, Han H, Min SK, Lee YS. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant. 2010;8:150-160.
5. Bella AJ, Hayashi N, Carrion RE, Price R, Lue TF. FK1706 enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat. J SexMed. 2007;4:341-346; discussion 346-347.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
7. Ceriello A. Hypothesis: the "metabolic memory,"the new challenge of diabetes. Diabetes Res Clin Pract. 2009;86:S2-S6.
8. Chen Y, Yang R, Yao L, Sun Z, Wang R, Dai Y. Differential expression of neurotrophins in penises of streptozotocin-induced diabetic rats. J Androl. 2007;28:306-312.
9. Chung BH, Kim JD, Kim CK, Kim JH, Won MH, Lee HS, Dong MS, Ha KS, Kwon YG, Kim YM. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochem Biophys Res Commun. 2008;376:404-408.
10. Dell'Agli M, Galli GV, Dal Cero E, Belluti F, Matera R, Zironi E, Pagliuca G, Bosisio E. Potent inhibition of human phosphodiesterase-5 by icariin derivatives. J Nat Prod. 2008;71:1513-1517.
11. Fedele D. Therapy insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat Clin Pract Urol. 2005;2:282-290; quiz 309.
12. Hidalgo-Tamola J, Chitaley K. Review type 2 diabetes mellitus and erectile dysfunction. J Sex Med. 2009;6:916-926.
13. Hsu GL, Brock G, Vonheyden B, Nunes L, Lue TF, Tanagho EA. The distribution of elastic fibrous elements within the human penis. Br J Urol. 1994;73:566-571.
14. Hyman KM, Seghezzi G, Pintucci G, Stellari G, Kim JH, Grossi EA, Galloway AC, Mignatti P. Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery. 2002;132:173-179.
15. Jin HR, Kim WJ, Song JS, Piao S, Choi MJ, Tumurbaatar M, Shin SH, Yin GN, Koh GY, Ryu JK, Suh JK. Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse. Diabetes. 2011;60:969-980.
16. Kandeel FR, Koussa VK, Swerdloff RS. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev. 2001;22:342-388.
17. Kovanecz I, Nolazco G, Ferrini MG, Toblli JE, Heydarkhan S, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction. BJU Int. 2009;103:1396-1404.
18. Lau DH, Kommu SS, Siddiqui EJ, Thompson CS, Morgan RJ, Mikhailidis DP, Mumtaz FH. Gene therapy and erectile dysfunction: the current status. Asian J Androl. 2007;9:8-15.
19. Liu T, Xin H, Li WR, Zhou F, Li GY, Gong YQ, Gao ZZ, Qin XC, Cui WS, Shindel AW, Xin ZC. Effects of icariin on improving erectile function in streptozotocin-induced diabetic rats. J Sex Med. 2011;8:2761-2772.
20. Liu WJ, Xin ZC, Xin H, Yuan YM, Tian L, Guo YL. Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats. Asian J Androl. 2005;7:381-388.
21. Martinez-Pineiro L, Brock G, Trigo-Rocha F, Hsu GL, Lue TF, Tanagho EA. Rat model for the study of penile erection: pharmacologic and electrical-stimulation parameters. Eur Urol. 1994; 25:62-70.
22. Moore CR, Wang R. Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl. 2006;8:675-684.
23. Moreland RB. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res. 1998;10:113-120.
24. Moreland RB, Traish A, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol. 1995;153:826-834.
25. Musicki B, Ross AE, Champion HC, Burnett AL, Bivalacqua TJ. Posttranslational modification of constitutive nitric oxide synthase in the penis. J Androl. 2009;30:352-362.
26. Ning H, Xin ZC, Lin G, Banie L, Lue TF, Lin CS. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006; 68:1350-1354.
27. Park JS, Park HY, Rho HS, Ahn S, Kim DH, Chang IS. Statistically designed enzymatic hydrolysis for optimized production of icariside II as a novel melanogenesis inhibitor. J Microbiol Biotechnol. 2008;18:110-117.
28. Pegge NC, Twomey AM, Vaughton K, Gravenor MB, Ramsey MW, Price DE. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment. Diabetic Med. 2006;23:873-878.
29. Rodriguez-Vita J, Sanchez-Galan E, Santamaria B, Sanchez-Lopez E, Rodrigues-Diez R, Blanco-Colio LM, Egido J, Ortiz A, Ruiz-Ortega M. Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation. PLoS ONE. 2008;3:e-3959.
30. Shindel AW, Xin ZC, Lin G, Fandel TM, Huang YC, Banie L, Breyer BN, Garcia MM, Lin CS, Lue TF. Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J Sex Med. 2010;7:1518-1528.
31. Usta MF, Kendirci M, Gur S, Foxwell NA, Bivalacqua TJ, Cellek S, Hellstrom WJ. The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocininduced diabetic rats: preventive versus curative treatment. J Sex Med. 2006;3:242-250.
32. Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res. 2002;14:466-471.
33. Wang H, Liu Y, Huai Q, Cai J, Zoraghi R, Francis SH, Corbin JD, Robinson H, Xin Z, Lin G, Ke H. Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development. J Biol Chem. 2006;281:21469-21479.
34. Wong MS, Hawthorne WJ, Manolios N. Gene therapy in diabetes. Self Nonself. 2010;1:165-175.
35. Xia Q, Xu D, Huang Z, Liu J, Wang X, Liu S. Preparation of icariside II from icariin by enzymatic hydrolysis method. Fitoterapia. 2010;81:437-442.
36. Xin ZC, Kim EK, Lin CS, Liu WJ, Tian L, Yuan YM, Fu J. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J Androl. 2003;5:15-18.
37. Xu W, Zhang Y, Yang M, Shen Z, Zhang X, Zhang W, Li H. LC-MS/ MS method for the simultaneous determination of icariin and its major metabolites in rat plasma. J Pharm Biomed Anal. 2007; 45:667-672.
38. Zhang LW, Piao S, Choi MJ, Shin HY, Jin HR, Kim WJ, Song SU, Han JY, Park SH, Mamura M, Kim SJ, Ryu JK, Suh JK. Role of increased penile expression of transforming growth factor-beta 1 and activation of the smad signaling pathway in erectile dysfunction in streptozotocin-induced diabetic rats. J Sex Med. 2008;5:2318-2329.
39. Zhang XM, Shi PH, Cao SH, Yu HJ, Azad J, Ling SC. Expression changes of transforming growth factor-beta1 and thrombospondin-1 in cavernous tissues of diabetic rats. Urol Int. 2010;84:221-225.